Published in J Biol Chem on February 16, 2010
Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. Cancer Res (2012) 1.01
Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals. Am J Hum Genet (2016) 0.90
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development. J Biol Chem (2012) 0.86
PIAS4 is associated with macro/microcephaly in the novel interstitial 19p13.3 microdeletion/microduplication syndrome. Eur J Hum Genet (2015) 0.81
The beta-catenin binding protein ICAT modulates androgen receptor activity. Mol Endocrinol (2011) 0.81
The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development. J Biol Chem (2011) 0.81
Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway. J Biol Chem (2013) 0.76
Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics (1996) 24.62
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A (2002) 8.57
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev (2001) 5.79
Formation of the androgen receptor transcription complex. Mol Cell (2002) 4.93
Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell (2001) 3.56
PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol (2002) 3.25
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci U S A (2002) 2.85
A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev (2001) 2.35
Linking beta-catenin to androgen-signaling pathway. J Biol Chem (2002) 2.27
SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell (2001) 2.23
Modulation of STAT signaling by STAT-interacting proteins. Oncogene (2000) 2.16
DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J Biol Chem (2001) 2.16
PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci (2003) 2.15
The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. EMBO J (2005) 2.12
Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem (1996) 2.05
PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J Biol Chem (2002) 1.90
The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem (2002) 1.57
ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol Endocrinol (2000) 1.55
A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J Biol Chem (1999) 1.51
PIAS proteins and transcriptional regulation--more than just SUMO E3 ligases? Genes Dev (2006) 1.50
Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech Dev (1997) 1.45
Regulation of cytokine signaling pathways by PIAS proteins. Cell Res (2006) 1.42
PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev (2006) 1.36
Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). J Biol Chem (2002) 1.33
hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J (2003) 1.28
PIASx acts as an Elk-1 coactivator by facilitating derepression. EMBO J (2005) 1.25
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Res (2007) 1.22
The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J Biol Chem (2006) 1.22
A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis. Apoptosis (2001) 1.15
hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol Endocrinol (2005) 1.11
Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J Biol Chem (2006) 1.10
Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med (2004) 1.07
The Drosophila trithorax group gene tonalli (tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING finger protein. Development (2003) 1.06
Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J Biol Chem (2002) 1.04
The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res (2007) 0.94
The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. Mol Cell Biol (2007) 0.93
PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2. FEBS Lett (2002) 0.89
Zimp7 and Zimp10, two novel PIAS-like proteins, function as androgen receptor coregulators. Nucl Recept Signal (2006) 0.87
Identification and characterization of a functional promoter region in the human eosinophil IL-5 receptor alpha subunit gene. J Biol Chem (1995) 0.86
Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proc Natl Acad Sci U S A (2006) 4.71
Linking beta-catenin to androgen-signaling pathway. J Biol Chem (2002) 2.27
Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. J Biol Chem (2002) 2.08
The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. Cancer Res (2007) 1.99
Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett (2005) 1.90
Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res (2004) 1.53
Bisphosphonates inhibit phosphorylation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signaling 3: implications for their effects on innate immune function and osteoclastogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 1.42
hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J (2003) 1.28
Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling. J Biol Chem (2003) 1.24
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Res (2007) 1.22
The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J Biol Chem (2006) 1.22
hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol Endocrinol (2005) 1.11
Radiation resistance of human melanoma analysed by retroviral insertional mutagenesis reveals a possible role for dopachrome tautomerase. Oncogene (2004) 1.10
LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin. Mol Cell Biol (2006) 1.07
Paternal influences on adolescent sexual risk behaviors: a structured literature review. Pediatrics (2012) 1.05
Identification of tyrosine kinases overexpressed in head and neck cancer. Arch Otolaryngol Head Neck Surg (2004) 1.04
Efficacy of c-Met inhibitor for advanced prostate cancer. BMC Cancer (2010) 1.03
Muscles of mice deficient in alpha-sarcoglycan maintain large masses and near control force values throughout the life span. Physiol Genomics (2005) 1.00
Human regulatory factor X 4 (RFX4) is a testis-specific dimeric DNA-binding protein that cooperates with other human RFX members. J Biol Chem (2001) 1.00
Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. Chem Res Toxicol (2011) 0.99
Monovision in LASIK. Ophthalmology (2007) 0.99
Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor. Mol Endocrinol (2004) 0.97
Gene trap and gene inversion methods for conditional gene inactivation in the mouse. Nucleic Acids Res (2005) 0.97
Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J Neuroimmunol (2006) 0.95
Visual impairment in the absence of dystroglycan. J Neurosci (2009) 0.94
The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res (2007) 0.94
The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. Mol Cell Biol (2007) 0.93
Effects of prefrontal cortical inactivation on neural activity in the ventral tegmental area. J Neurosci (2013) 0.92
Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. Toxicol Appl Pharmacol (2009) 0.89
Zimp7 and Zimp10, two novel PIAS-like proteins, function as androgen receptor coregulators. Nucl Recept Signal (2006) 0.87
Attenuation of DNA damage-induced p53 expression by arsenic: a possible mechanism for arsenic co-carcinogenesis. Mol Carcinog (2008) 0.87
Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells. Anticancer Res (2009) 0.86
Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate. J Biol Chem (2011) 0.86
Direct transcriptional regulation of MDM2 by Fli-1. Oncogene (2005) 0.86
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development. J Biol Chem (2012) 0.86
Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors. PLoS One (2013) 0.85
Latino Adolescent Reproductive and Sexual Health Behaviors and Outcomes: Research Informed Guidance for Agency-based Practitioners. Clin Soc Work J (2011) 0.85
Genetic predisposition to the cytotoxicity of arsenic: the role of DNA damage and ATM. FASEB J (2003) 0.85
In-stent restenosis limitation with stent-based controlled-release nitric oxide: initial results in rabbits. Radiology (2003) 0.85
Effects of nicotine on target biting and resident-intruder attack. Life Sci (2003) 0.82
Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. Pediatr Allergy Immunol (2008) 0.82
Intracavity ionization and pulse formation in femtosecond enhancement cavities. Opt Lett (2011) 0.82
The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development. J Biol Chem (2011) 0.81
Methodologic advancements in the study of airway smooth muscle. J Allergy Clin Immunol (2004) 0.81
The beta-catenin binding protein ICAT modulates androgen receptor activity. Mol Endocrinol (2011) 0.81
Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol (2006) 0.80
Socio-environmental risks for untreated depression among formerly incarcerated Latino men. J Immigr Minor Health (2014) 0.80
Identification and characterization of an epididymis-specific gene, Ces7. Acta Biochim Biophys Sin (Shanghai) (2009) 0.80
ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. PLoS One (2011) 0.80
Autophagy downregulates thrombin-induced VSMCs proliferation through lysosomal pathway. Int J Cardiol (2012) 0.79
Stent-based controlled release of intravascular angiostatin to limit plaque progression and in-stent restenosis. J Vasc Interv Radiol (2004) 0.79
A novel zinc finger transcription factor with two isoforms that are differentially repressed by estrogen receptor-alpha. J Biol Chem (2002) 0.79
An Hsp27-related, dominant-negative-acting intracellular estradiol-binding protein. J Biol Chem (2004) 0.79
Development and certification of the new NIES CRM 28: urban aerosols for the determination of multielements. Anal Bioanal Chem (2008) 0.78
Efficient inhibition of in-stent restenosis by controlled stent-based inhibition of elastase: a pilot study. J Vasc Interv Radiol (2004) 0.78
Development and expression of amyloid-β peptide 42 in retinal ganglion cells in rats. Anat Rec (Hoboken) (2011) 0.78
Arsenite and its mono- and dimethylated trivalent metabolites enhance the formation of benzo[a]pyrene diol epoxide-DNA adducts in Xeroderma pigmentosum complementation group A cells. Chem Res Toxicol (2009) 0.77
HIV sexual risk behavior and family dynamics in a Dominican tourism town. Arch Sex Behav (2013) 0.77
Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women: A Cross-Sectional Study. Medicine (Baltimore) (2016) 0.77
S100+ cells: a new neuro-immune cross-talkers in lymph organs. Sci Rep (2013) 0.77
Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development. Methods Mol Biol (2011) 0.77
Hypothalamic-Pituitary-Gonadal Axis in Aging Men and Women: Increasing Total Testosterone in Aging Men. Neuroendocrinology (2016) 0.76
Yields of damage to C4' deoxyribose and to pyrimidines in pUC18 by the direct effect of ionizing radiation. Nucleic Acids Res (2012) 0.76
Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway. J Biol Chem (2013) 0.76
Directed migration of smooth muscle cells to engineer plaque-resistant vein grafts. J Endovasc Ther (2005) 0.76
Cloning and primary characterizations of rLcn9, a new member of epididymal lipocalins in rat. Acta Biochim Biophys Sin (Shanghai) (2012) 0.75
Elevation of cellular BPDE uptake by human cells: a possible factor contributing to co-carcinogenicity by arsenite. Environ Health Perspect (2006) 0.75
Predictors of the length of stay in a psychiatric emergency care centre. Australas Psychiatry (2013) 0.75
A centralized storage system for the delivery of subcutaneous infusions. Br J Nurs (2008) 0.75
Immunofluorescence detection of radiation-induced DNA base damage. Mil Med (2002) 0.75
[Impact of AR-V7 expression on overall survival for patients with metastatic prostate cancer]. Zhonghua Wai Ke Za Zhi (2014) 0.75
Safety and efficacy of RT002, an injectable botulinum toxin type A, for treating glabellar lines: results of a phase 1/2, open-label, sequential dose-escalation study. Dermatol Surg (2015) 0.75
Emotions and cognitions as correlates of early adolescent sexual behavior among Dominican youth in the United States and Dominican Republic. AIDS Behav (2013) 0.75
Generation of high-power frequency combs from injection-locked femtosecond amplification cavities. Opt Lett (2008) 0.75